In cancer treatment, HDAC inhibitors are used to induce cell cycle arrest and cell death by increasing gene transcription, such genes involved in both intrinsic, BAX, BAK, APAF1, and extrinsic, TRAIL, DR5, FAS, FAS-L, and TNF-α, apoptotic pathways [80]. Here, HDAC9 is linked to cancer.